Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Todd R. Brady currently holds 19,000 shares of Contineum Therapeutics, Inc. (CTNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Todd R. Brady has been a net neutral trader of CTNM stock. They have purchased $0 and sold $0 worth of shares.
Todd R. Brady's most recent insider trade was on Jun 26, 2026, when they sold 19,000 shares at $0.00 per share.
Todd R. Brady serves as Executive at Contineum Therapeutics, Inc. (CTNM). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Todd R. Brady holds the position of Executive at Contineum Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Todd R. Brady has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Todd R. Brady was on Jun 26, 2026, when they purchased $0 worth of CTNM shares. This transaction involved 19,000 shares at N/A per share.
Todd R. Brady currently owns 19,000 shares of Contineum Therapeutics, Inc. (CTNM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Todd R. Brady's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Todd R. Brady has 2 Form 4 filings on record as an insider at Contineum Therapeutics, Inc..
Set alerts for Todd R. Brady and 40,000+ other insiders.